|
Active substance |
Leriglitazone |
|
Holder |
Minoryx Therapeutics BE, SA |
|
Statut |
Running |
|
Indication |
Treatment of Friedreich’s Ataxia. |
|
Public documents |
|
|
Last update |
09/08/2022 |
Leriglitazone
Last updated on 23/04/2024